Helius To Bring Its Innovative PoNS Therapy For Improvement Of Gait In People With MS, To The 2023 Academy Of Neurologic Physical Therapy Conference
Portfolio Pulse from Benzinga Newsdesk
Helius Medical Technologies, Inc. plans to showcase its Portable Neuromodulation Stimulator (PoNS) therapy at the 2023 Academy of Neurologic Physical Therapy Conference. The therapy is designed to improve gait in people with Multiple Sclerosis (MS). This will be the company's first-ever ANPT booth sponsorship.
September 21, 2023 | 11:07 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Helius Medical Technologies' showcasing of its PoNS therapy at the 2023 ANPT Conference could potentially increase awareness and adoption of the therapy, potentially leading to increased revenues.
The showcasing of Helius' PoNS therapy at a major conference increases its visibility among specialists, which could lead to increased adoption of the therapy. This could potentially lead to increased revenues for the company, positively impacting its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100